Effects of the COVID-19 lockdown on glycaemic control in subjects with type 2 diabetes: the glycalock study
Open Access
- 30 June 2021
- journal article
- research article
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 23 (7), 1624-1630
- https://doi.org/10.1111/dom.14380
Abstract
Aim To assess the effect of the coronavirus disease 2019 (COVID-19) lockdown on glycaemic control in subjects with type 2 diabetes (T2D). Materials and Methods In this observational, multicentre, retrospective study conducted in the Lazio region, Italy, we compared the differences in the HbA1c levels of 141 subjects with T2D exposed to lockdown with 123 matched controls with T2D who attended the study centres 1 year before. Basal data were collected from 9 December to 9 March and follow-up data from 3 June to 10 July in 2020 for the lockdown group, and during the same timeframes in 2019 for the control groups. Changes in HbA1c (Delta HbA1c) and body mass index (Delta BMI) during lockdown were compared among patients with different psychological well-being, as evaluated by tertiles of the Psychological General Well-Being Index (PGWBS). Results No difference in Delta HbA1c was found between the lockdown and control groups (lockdown group -0.1% [-0.5%-0.3%] vs. control group -0.1% [-0.4%-0.2%]; p = .482). Also, no difference was found in Delta BMI (p = .316) or Delta Glucose (p = .538). In the lockdown group, subjects with worse PGWBS showed a worsening of HbA1c (p = .041 for the trend among PGWBS tertiles) and BMI (p = .022). Conclusions The COVID-19 lockdown did not significantly impact glycaemic control in people with T2D. People with poor psychological well-being may experience a worsening a glycaemic control because of restrictions resulting from lockdown. These findings may aid healthcare providers in diabetes management once the second wave of COVID-19 has ended.Keywords
This publication has 15 references indexed in Scilit:
- Effects of COVID-19 lockdown on type 2 diabetes, lifestyle and psychosocial health: A hospital-based cross-sectional survey from South IndiaDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020
- Mental health in the era of COVID-19: prevalence of psychiatric disorders in a cohort of patients with type 1 and type 2 diabetes during the social distancingDiabetology & Metabolic Syndrome, 2020
- Observational study on Effect of Lock Down due to COVID 19 on glycemic control in patients with Diabetes: Experience from Central IndiaDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020
- Metformin use is associated with reduced mortality rate from coronavirus disease 2019 (COVID-19) infectionObesity Medicine, 2020
- Impact of COVID-19 pandemic on mental health in the general population: A systematic reviewJournal of Affective Disorders, 2020
- Effects of COVID-19 Lockdown on Glucose Control: Continuous Glucose Monitoring Data From People With Diabetes on Intensive Insulin TherapyDiabetes Care, 2020
- Blood Glucose Control During Lockdown for COVID-19: CGM Metrics in Italian Adults With Type 1 DiabetesDiabetes Care, 2020
- COVID-19 in people with diabetes: understanding the reasons for worse outcomesThe Lancet Diabetes & Endocrinology, 2020
- Frailty and geography: should these two factors be added to the ABCDE contemporary guide to diabetes therapy?Diabetes/Metabolism Research and Reviews, 2015
- Development and validation of the short version of the Psychological General Well-Being Index (PGWB-S)Health and Quality of Life Outcomes, 2006